Hikma Pharmaceuticals (HKMPF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 359M 190M 188M 421M
    Depreciation & Amortization
    		 197M 190M 182M 169M
    Stock-Based Compensation
    		 27M 25M 22M 29M
    Other Working Capital
    		 43M 131M -49M 86M
    Other Non-Cash Items
    		 194M 211M 160M 48M
    Deferred Income Tax
    		 n/a n/a 76M 99M
    Change in Working Capital
    		 -213M -8M -98M -128M
    Operating Cash Flow
    		 564M 608M 530M 638M
    Capital Expenditures
    		 -165M -169M -138M -145M
    Cash Acquisitions
    		 -150M -105M -380M -17M
    Purchase of Investments
    		 n/a -27M -15M -3M
    Sales Maturities Of Investments
    		 n/a 1M 395M 6M
    Other Investing Acitivies
    		 -66M -33M -469M -79M
    Investing Cash Flow
    		 -381M -333M -607M -238M
    Debt Repayment
    		 124M -73M 430M -83M
    Common Stock Repurchased
    		 n/a n/a -300M n/a
    Dividend Paid
    		 -175M -137M -125M -120M
    Other Financial Acitivies
    		 -137M -127M -63M -84M
    Financial Cash Flow
    		 -188M -337M -58M -287M
    Net Cash Flow
    		 -17M -65M -156M 103M
    Free Cash Flow
    		 399M 439M 392M 493M

    Add to Watchlist